35 results
DEFA14A
ACGN
Aceragen Inc
30 Sep 22
Additional proxy soliciting materials
4:18pm
and its Subsidiaries operate, (b) acts of war, armed hostilities or terrorism, acts of God or comparable events, epidemic, pandemic or disease outbreak … affecting the industry in which Parent operates, (b) acts of war, armed hostilities or terrorism, acts of God or comparable events, epidemic, pandemic
8-K
EX-2.1
xx93zw
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
ug5l 0dz1v
9 Aug 22
Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
2p2b6b9xfxarw onbb
17 May 22
Idera Pharmaceuticals Shares Positive Results from Investigator- Sponsored Trial in Melanoma Patients at Amsterdam UMC
10:14am
8-K
EX-99.1
8xlsioo cklup
5 May 22
Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
fe8epm oyfoa
31 Mar 22
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:20pm
8-K
EX-99.1
cv51ny
14 Dec 21
Idera Pharmaceuticals Announces Tilsotolimod Updates
4:45pm
8-K
9fw9axzaey7n vwy9s
1 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
EX-99.1
sp4joz2
8 Nov 21
Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-99.1
zsnpr
9 Aug 21
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
mskc362kcfjqwj1z
18 May 21
Idera Pharmaceuticals Announces Corporate Updates
4:41pm